Renal patients, especially those with moderate-to-severe chronic kidney disease (CKD) are prone to hematological abnormalities, especially severe anemia, mainly due to the reduced secretion of erythropoietin and impaired erythrocyte survival in the uremic toxic environment. Here, EPO is linked to anemia (phenotype).